Clinical Trials at KLB Gesundheitsforschung Lübeck GmbH
During the past decade, KLB Gesundheitsforschung Lübeck GmbH conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on
average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
A Study to Test the Combination of Tiotropium and Olodaterol Using the Respimat® Inhaler in People With Chronic Obstructive Pulmonary Disease (COPD) Who Have Different Abilities to Inhale
A Study to Assess the Safety, Tolerability, and Efficacy of ION-827359 in Participants With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis (CB)
A Study in Patients With Non-cystic Fibrosis Bronchiectasis to Test How Well Different Doses of BI 1323495 Are Tolerated and How BI 1323495 Affects Biomarkers of Inflammation
2021-03-04
2022-01-19
Completed
7
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "KLB Gesundheitsforschung Lübeck GmbH"
#1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator and "German Federal Ministry of Education and Research" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at KLB Gesundheitsforschung Lübeck GmbH
According to Clinical.Site data, the most researched conditions in "KLB Gesundheitsforschung Lübeck GmbH" are
"Pulmonary Disease, Chronic Obstructive" (4 trials), "Asthma" (2 trials), "Bronchiectasis" (1 trials), "Chronic Bronchitis" (1 trials) and "Chronic Obstructive Pulmonary Disease" (1 trials). Many other conditions were trialed in "KLB Gesundheitsforschung Lübeck GmbH" in a lesser frequency.
Clinical Trials Intervention Types at KLB Gesundheitsforschung Lübeck GmbH
Most popular intervention types in "KLB Gesundheitsforschung Lübeck GmbH" are "Drug" (8 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "BI 1026706" (1 trials), "BI 1291583" (1 trials), "BI 1323495" (1 trials) and "Fluticasone propionate" (1 trials). Other intervention names were less common.
Clinical Trials Genders at KLB Gesundheitsforschung Lübeck GmbH
The vast majority of trials in "KLB Gesundheitsforschung Lübeck GmbH" are
9 trials for "All" genders.
Clinical Trials Status at KLB Gesundheitsforschung Lübeck GmbH
Currently, there are NaN active trials in "KLB Gesundheitsforschung Lübeck GmbH".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in KLB Gesundheitsforschung Lübeck GmbH,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in KLB Gesundheitsforschung Lübeck GmbH, 2 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 0 trials that are defined as “Not Applicable".